Pfizer Statistics

Total Valuation

Pfizer has a market cap or net worth of GBP 111.08 billion. The enterprise value is 146.54 billion.

Market Cap	111.08B
Enterprise Value	146.54B

Important Dates

The next estimated earnings date is Tuesday, February 3, 2026.

Earnings Date	Feb 3, 2026
Ex-Dividend Date	Nov 7, 2025

Share Statistics

Current Share Class	5.69B
Shares Outstanding	n/a
Shares Change (YoY)	+0.18%
Shares Change (QoQ)	+0.14%
Owned by Insiders (%)	0.02%
Owned by Institutions (%)	66.51%
Float	5.68B

Valuation Ratios

The trailing PE ratio is 15.16 and the forward PE ratio is 8.75.

PE Ratio	15.16
Forward PE	8.75
PS Ratio	2.37
PB Ratio	1.60
P/TBV Ratio	n/a
P/FCF Ratio	14.36
P/OCF Ratio	11.39
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.62, with an EV/FCF ratio of 18.94.

EV / Earnings	19.99
EV / Sales	3.11
EV / EBITDA	7.62
EV / EBIT	10.98
EV / FCF	18.94

Financial Position

The company has a current ratio of 1.28, with a Debt / Equity ratio of 0.67.

Current Ratio	1.28
Quick Ratio	0.90
Debt / Equity	0.67
Debt / EBITDA	2.42
Debt / FCF	5.97
Interest Coverage	6.59

Financial Efficiency

Return on equity (ROE) is 10.60% and return on invested capital (ROIC) is 7.04%.

Return on Equity (ROE)	10.60%
Return on Assets (ROA)	5.19%
Return on Invested Capital (ROIC)	7.04%
Return on Capital Employed (ROCE)	10.33%
Revenue Per Employee	578,002
Profits Per Employee	90,486
Employee Count	81,000
Asset Turnover	0.29
Inventory Turnover	1.36

Taxes

Income Tax	-510.80M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +2.89% in the last 52 weeks. The beta is 0.43, so Pfizer's price volatility has been lower than the market average.

Beta (5Y)	0.43
52-Week Price Change	+2.89%
50-Day Moving Average	25.13
200-Day Moving Average	24.60
Relative Strength Index (RSI)	59.88
Average Volume (20 Days)	159,657

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.93

Income Statement

In the last 12 months, Pfizer had revenue of GBP 46.82 billion and earned 7.33 billion in profits. Earnings per share was 1.29.

Revenue	46.82B
Gross Profit	35.02B
Operating Income	13.26B
Pretax Income	6.83B
Net Income	7.33B
EBITDA	18.24B
EBIT	13.26B
Earnings Per Share (EPS)	1.29

Full Income Statement

Balance Sheet

The company has 11.17 billion in cash and 46.19 billion in debt, giving a net cash position of -35.01 billion.

Cash & Cash Equivalents	11.17B
Total Debt	46.19B
Net Cash	-35.01B
Net Cash Per Share	n/a
Equity (Book Value)	69.42B
Book Value Per Share	12.17
Working Capital	7.70B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 9.75 billion and capital expenditures -2.01 billion, giving a free cash flow of 7.74 billion.

Operating Cash Flow	9.75B
Capital Expenditures	-2.01B
Free Cash Flow	7.74B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 74.81%, with operating and profit margins of 28.31% and 15.66%.

Gross Margin	74.81%
Operating Margin	28.31%
Pretax Margin	14.58%
Profit Margin	15.66%
EBITDA Margin	38.96%
EBIT Margin	28.31%
FCF Margin	16.53%

Dividends & Yields

This stock pays an annual dividend of 1.31, which amounts to a dividend yield of 5.09%.

Dividend Per Share	1.31
Dividend Yield	5.09%
Dividend Growth (YoY)	-0.29%
Years of Dividend Growth	1
Payout Ratio	98.75%
Buyback Yield	-0.18%
Shareholder Yield	4.90%
Earnings Yield	6.60%
FCF Yield	6.97%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on July 1, 1999. It was a forward split with a ratio of 3.

Last Split Date	Jul 1, 1999
Split Type	Forward
Split Ratio	3

Scores

Pfizer has an Altman Z-Score of 2.2 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.2
Piotroski F-Score	7